Page last updated: 2024-08-24

tenofovir and Acquired Immune Deficiency Syndrome

tenofovir has been researched along with Acquired Immune Deficiency Syndrome in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.11)	18.2507
2000's	31 (34.44)	29.6817
2010's	38 (42.22)	24.3611
2020's	20 (22.22)	2.80

Authors

Authors	Studies
Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF	1
Bamford, L; Burkholder, GA; Cachay, ER; Christopoulos, K; Crane, HM; Delaney, JAC; Eron, JJ; Gravett, RM; Jacobson, JM; Keruly, J; Kitahata, MM; Ma, J; Martin, J; Mayer, KH; Moore, RD; Nance, RM; Napravnik, S; Saag, MS; Whitney, BM	1
Chen, M; Meng, W; Song, Y; Xie, R; Zhang, F; Zhang, H	1
Ehteshami, M; Patel, D; Schinazi, RF	1
Ahmed, K; Baeten, JM; Beesham, I; Beksinska, M; Heffron, R; Joseph Davey, DL; Kotze, P; Louw, C; Mansoor, LE; Palanee-Phillips, T; Parikh, UM; Rees, H; Selepe, P; Singata-Madliki, M; Smit, J; Wiesner, L	1
Adebisi, SA; Adedeji, NO; Adedeji, TA; Ajeigbe, AK; Ajose, AO; Akande, AA; Fawale, MB; Jeje, OA; Okesina, BA; Smith, OS	1
Brandão, LAC; Coelho, AVC; De Araújo, PSR; De Melo, HRL; Lima, K; Soares, RCA	1
Andreoni, M; Barchi, V; De Simone, G; Iannazzo, R; Iannetta, M; Massa, B; Rindi, LV; Sarmati, L	1
Fan, L; Gao, L; Hu, Y; Huang, R; Li, L; Ma, P; Qiu, C; Wu, Y; Yu, A; Zhang, D	1
Fotooh Abadi, L; Gajbhiye, V; Kulkarni, S; Kumar, P; Paknikar, K	1
Abgrall, S; Allavena, C; Bernard, L; Bregigeon, S; Caby, F; Capeau, J; Costagliola, D; de Truchis, P; Duvivier, C; Enel, P; Grabar, S; Katlama, C; Khuong, MA; Launay, O; Matheron, S; Melica, G; Melliez, H; Meynard, JL; Pavie, J; Piroth, L; Potard, V; Slama, L; Tattevin, P	1
Asselin, J; Carter, A; Chen, M; Donovan, B; Gracey, DM; Grulich, A; Guy, R; Heron, JE; Lewis, DA; McManus, H; O'Connor, CC; Ryan, K; Ryder, N; Stoove, M; Templeton, DJ; Varma, R; Vickers, T; Wright, E	1
Allavena, C; Arvieux, C; Becker, A; Cabié, A; Chéret, A; Delpierre, C; Duvivier, C; Hocqueloux, L; Joly, V; Menard, A	1
Althoff, KN; Cachay, ER; Carbonari, DM; Chew, K; Coburn, SB; Gebo, KA; Gill, MJ; Horberg, MA; Hull, M; Kim, HN; Kim, J; Kirk, GD; Kitahata, MM; Klein, MB; Lang, R; Lim, JK; Lo Re, V; Mayor, AM; McGinnis, KA; Moore, RD; Napravnik, S; Newcomb, CW; Reddy, KR; Seaberg, EC; Silverberg, MJ; Sterling, TR; Torgersen, J	1
Adeyeye, A; Cardozo, N; Cohen, MS; Coutinho, C; Donnell, D; Eshleman, SH; Feliciano, KG; Ford, S; Franks, J; Grinsztejn, B; Hanscom, B; Jalil, E; Jennings, A; Khan, T; Landovitz, RJ; Lucas, J; Maia, B; Marzinke, MA; McCauley, M; Middelkoop, K; Psaros, C; Richardson, PA; Rinehart, AR; Rooney, JF; Safren, SA; Sanchez, N; Singh, Y; Sullivan, P; Valencia, J; Wang, Z	1
Alagaratnam, J; Ambrosioni, J; Bamford, A; Boesecke, C; Calmy, A; Cinque, P; Guaraldi, G; Koval, A; Levi, L; Martínez, E; Marzolini, C; Mastrangelo, A; Mendao, L; Molina, JM; Oprea, C; Rockstroh, JK; Van Bremen, K; Waalewijn, H; Welch, S; Winston, A	1
Adeyeye, A; Anderson, PL; Berman, R; Clement, ME; Cohen, MS; Del Rio, C; Donnell, D; Eron, JJ; Eshleman, SH; Fields, SD; Grinsztejn, B; Hanscom, BS; Hendrix, CW; Kallas, EG; Kofron, RM; Landovitz, RJ; Lucas, JP; Magnus, M; Marzinke, MA; McCauley, M; Piwowar-Manning, EM; Richardson, PA; Rinehart, AR; Rooney, JF; Sanchez, J; Scott, H; Spinelli, MA; Sued, O; Sullivan, PA; Tran, HV	1
Li, A; Li, C; Li, H; Li, W; Li, X; Xia, W	1
Chen, HP; Chou, RY; Guo, JY; Tai, CC	1
Foreman, RM; Zappas, MP	1
Avelino-Silva, VI; Carvalhanas, T; Costa, AF; Domingues, CSB; Ferreira, PM; Ferreira, PRA; Furtado, JJD; Gianna, MC; Gomes E Costa, DA; Jamal, LF; Kalichman, AO; Leite, OHM; Rocha, SQ; Souza, RA; Souza, TNL; Tancredi, MV; Tayra, A	1
Brookhart, MA; Cole, SR; Crane, HM; Edwards, JK; Eron, JJ; Hall, HI; Kitahata, MM; Mathews, WC; Moore, RD; Mugavero, MJ; Saag, MS	1
Ankrah, DNA; Lartey, M; Leufkens, HGM; Mantel-Teeuwisse, AK	1
Akunuri, S; Kallampallil, J; Leong, S; Maweni, R	1
Hope, TJ	1
Folayan, MO; Peterson, K	1
Choi, J; Nikoomanesh, K; Uppal, J; Wang, S	1
Amariles, P; Castañeda, C; Galindo, J; Mueses-Marín, HF	1
Amico, KR; Bekker, LG; Chitwarakorn, A; Dye, BJ; Grant, RM; Hendrix, CW; Holtz, TH; Hughes, JP; Li, M; Mannheimer, S; Marzinke, M; Ojeda, VD; Wilson, E	1
Barry, MJ; Cabana, M; Caughey, AB; Curry, SJ; Davidson, KW; Doubeni, CA; Epling, JW; Krist, AH; Kubik, M; Landefeld, CS; Mangione, CM; Owens, DK; Pbert, L; Silverstein, M; Simon, MA; Tseng, CW; Wong, JB	1
Allen, ME; Brown, J; Karakas, SE; Pollard, RB	1
Hawkes, N	1
Oyler, NA; Youan, BC; Zhang, C; Zhang, T	1
Arnedo, M; Domingo, P; Egaña-Gorroño, L; Escribà, T; Fontdevila, J; Gatell, JM; Loncà, M; Martínez, E; Negredo, E; Vidal, F	1
Acosta, EP; Daar, ES; Haas, DW; Li, C; Morse, GD; Shepherd, BE; Venuto, C; Wanga, V	1
Cohen, J	2
Guedj, R	1
Andrews, M; Condoluci, DV; Luber, AD	1
Barkil, ME; Boibieux, A; Cotte, L; Gagnieu, MC; Guitton, J; Livrozet, JM; Miailhes, P; Tod, M	1
Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M	1
Mohammadi, D	1
Boissier, MC; Prendki, V; Prie, D; Saidenberg-Kermanac'h, N; Souabni, L	1
Wainberg, MA	1
Arrivé, E; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; Kone, M; Kruy, LS; Nerrienet, E; Nyati, M; Pruvost, A; Tréluyer, JM; Urien, S	1
Amani-Bosse, C; Arrivé, E; Avit, D; Blanche, S; Dabis, F; Ek, ML; Ekouévi, DK; Hirt, D; Legote, S; McIntyre, J; Nyati, M; Pruvost, A; Say, L; Tréluyer, JM; Urien, S	1
Hakim, JG; Katsidzira, L	1
Andrade-Villanueva, J; Boven, K; Clotet, B; Cohen, CJ; Crauwels, H; Fourie, J; Johnson, MA; Rimsky, LT; Ruxrungtham, K; Vanveggel, S; Wu, H; Zorrilla, C	1
Boven, K; Cahn, P; Crauwels, H; Grinsztejn, B; Lazzarin, A; Mills, A; Molina, JM; Rimsky, LT; Saag, M; Supparatpinyo, K; Vanveggel, S; Walmsley, S	1
Donnelly, J	1
Blanch, J; Cervantes, M; Domingo, P; Ferrer, E; Knobel, H; Llibre, JM; Mallolas, J; Pedrol, E; Vallecillo, G	1
Couto, ER; de Rezende, SM; Moretti, ML; Morsch Passos, AI	1
Venkataramanan, M	1
Buckheit, KW; Buckheit, RW; Goldman, L; Gwozdz, G; Ham, AS; Kiser, PF; Lakougna, H; Nagaraja, U; Shi, L; Ugaonkar, SR	1
Arasteh, K; Boven, K; Crauwels, H; De Wet, J; Gathe, J; Gold, J; Hodder, S; Kumar, P; Mohapi, L; Short, W; Vanveggel, S	1
Islam, FM; Jansson, J; Wilson, DP; Wu, J	1
Aga, E; Badal-Faesen, S; Bartlett, JA; Crump, JA; Hosseinipour, MC; Kallungal, BA; Katzenstein, DA; Klingman, KL; Kumarasamy, N; Norton, MR; Ribaudo, HJ; Stevens, WS; Supparatpinyo, K; Wallis, CL	1
Goicochea, P; Grant, RM; Liu, A; Marcus, JL; McMahan, V; R Amico, K; Vargas, L	1
Bloom, A; Brown, TT; Daar, ES; Fedarko, N; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C	1
Powderly, WG	1
Casado, JL; del Palacio, M; Romero, S	1
Carda-Broch, S; Casas-Breva, I; Esteve-Romero, J; Peris-Vicente, J; Rambla-Alegre, M	1
Ambrosioni, J; Calmy, A; Daou, S; Merkler, D	1
Gallant, JE	1
Aries, SP; Dalhoff, K; Kramme, E; Schaaf, B; Steinhoff, J	1
Clarke, B	1
Abad, S; Blanche, P; Chauvelot-Moachon, L; Daniel, N; Kélaïdi, C; Nazal, EM; Rollot, F; Saba, M	1
Benhamou, Y; Poynard, T	1
Chen, SS; Cheng, A; Lu, B; Margot, N; Miller, MD; Wulfsohn, M; Zhong, L	1
Dressier, RM; James, CW; Steinhaus, MC; Szabo, S	1
Perazella, MA; Rifkin, BS	1
Cheng, AK; Coakley, DF; Margot, NA; McColl, DJ; Miller, MD; Wulfsohn, M	1
Abraira, V; Antela, A; Casado, JL; Dronda, F; Gutiérrez, C; López, D; Moreno, A; Moreno, S; Pérez-Elías, MJ; Rodríguez, MA	1
Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J	1
Abraham, P; Malik, A; Malik, N	1
de la Prada, FJ; Morey, A; Prados, AM; Saus, C; Tugores, A; Uriol, M	1
Bainbridge, A; Jäger, HR; Miller, RF; Usiskin, SI	1
Fernández Lisón, LC; Hevia Alonso, A; Pujol de la Llave, E; Rodríguez Gómez, FJ; Vázquez Domínguez, B	1
Amoroso, A; Cleghorn, FR; Davis, CE; Gilliam, BL; Redfield, RR; Sajadi, MM	1
Ahya, SN; Kanwar, YS; Palella, F; Patel, SM; Zembower, TR	1
Folks, TM; Sandstrom, PA	1
Adams, DR; Butera, S; Folks, TM; Jackson, E; Jaffe, H; Janssen, R; Kim, CN; Otten, RA; Pullium, JK; Smith, DK	1

Reviews

12 review(s) available for tenofovir and Acquired Immune Deficiency Syndrome

Article	Year
The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir. Antiviral therapy, 2022, Volume: 27, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Emtricitabine; HIV Infections; HIV-1; Humans; Male; Tenofovir	2022
Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review. Sexual health, 2020, Volume: 17, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Alanine; Antiviral Agents; Humans; Hypokalemia; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Tenofovir	2020
[AIDS: ethics and scientific investigation on human beings]. Bulletin de la Societe de pathologie exotique (1990), 2008, Volume: 101, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Anti-HIV Agents; Azathioprine; Clinical Trials as Topic; Congresses as Topic; Cyclosporine; Developing Countries; Ditiocarb; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethics Committees, Research; Human Experimentation; Humans; Informed Consent; Mass Media; Oligodeoxyribonucleotides, Antisense; Organophosphonates; Practice Guidelines as Topic; Stavudine; Tenofovir; Thionucleotides	2008
HIV prevention in southern Africa: why we must reassess our strategies? Tropical medicine & international health : TM & IH, 2011, Volume: 16, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adolescent; Adult; Anti-HIV Agents; Circumcision, Male; Condoms; Condoms, Female; Female; HIV Infections; HIV Seropositivity; Humans; Interdisciplinary Communication; Male; Middle Aged; Organophosphonates; Preventive Medicine; Risk Reduction Behavior; Tenofovir; Young Adult	2011
Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC public health, 2012, Mar-23, Volume: 12 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Chronic Disease; Female; HIV Infections; Humans; Kidney Diseases; Male; Odds Ratio; Organophosphonates; Survival Rate; Tenofovir	2012
Osteoporosis and bone health in HIV. Current HIV/AIDS reports, 2012, Volume: 9, Issue:3 Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adenine; Alcohol Drinking; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Density Conservation Agents; Female; Humans; Inflammation; Male; Organophosphonates; Osteomalacia; Osteoporosis; Osteoporotic Fractures; Smoking; Tenofovir; Weight Loss	2012
The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients. Current HIV research, 2012, Volume: 10, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; Organophosphonates; Retinol-Binding Proteins; Reverse Transcriptase Inhibitors; Tenofovir	2012
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature. AIDS (London, England), 2013, Feb-20, Volume: 27, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Decompressive Craniectomy; Dideoxynucleosides; Female; Humans; Intracranial Hypertension; Lopinavir; Medication Adherence; Meningoencephalitis; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome	2013
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus. Journal of hepatology, 2003, Volume: 39 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir	2003
Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy, 2004, Volume: 24, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Clinical Chemistry Tests; Fanconi Syndrome; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome	2004
Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature. The Journal of infection, 2005, Volume: 51, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Humans; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome	2005
New strategies for treating AIDS. BioEssays : news and reviews in molecular, cellular and developmental biology, 1996, Volume: 18, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; Capsid; Drug Design; Drug Resistance, Microbial; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Viral Core Proteins; Virus Replication; Zinc Fingers	1996

Trials

17 trial(s) available for tenofovir and Acquired Immune Deficiency Syndrome

Article	Year
Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. Journal of acquired immune deficiency syndromes (1999), 2022, 09-01, Volume: 91, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Medication Adherence; Pre-Exposure Prophylaxis; South Africa; Tenofovir; Young Adult	2022
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial. The lancet. HIV, 2023, Volume: 10, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; HIV-1; Hormones; Humans; Male; Pre-Exposure Prophylaxis; Tenofovir; Thailand; Transgender Persons	2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary anal The lancet. HIV, 2023, Volume: 10, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Pre-Exposure Prophylaxis; Retrospective Studies; Tenofovir; Transgender Persons	2023
[Effectiveness and safety of generic version of lamivudine/tenofovir and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2012-2014]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2019, Volume: 36, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Colombia; Cyclopropanes; Drugs, Generic; Female; Humans; Lamivudine; Male; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Tenofovir; Time Factors; Treatment Outcome; Young Adult	2019
Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adipogenesis; Adiponectin; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; CCAAT-Enhancer-Binding Proteins; Cyclopropanes; Deoxycytidine; Drug Combinations; Emtricitabine; Energy Metabolism; Female; Gene Expression; Glucose; Glucose Transporter Type 4; HIV-1; Humans; Inflammation; Lipid Metabolism; Lipoprotein Lipase; Lopinavir; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Subcutaneous Fat; Tenofovir	2014
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. Pharmacogenetics and genomics, 2015, Volume: 25, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Creatinine; Cyclopropanes; Dideoxynucleosides; Female; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Ritonavir; Tenofovir	2015
Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2). Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Organophosphonates; Phosphorylation; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir	2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2). Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2011
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Nucleosides; Nucleotides; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load	2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load	2011
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. HIV medicine, 2012, Volume: 13, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black or African American; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Nitriles; Organophosphonates; Pyrimidines; Rilpivirine; Sex Factors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine	2012
Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS and behavior, 2012, Volume: 16, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Deoxycytidine; Directive Counseling; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphonates; Patient Acceptance of Health Care; Self Report; Sexual Partners; Tenofovir; Transsexualism	2012
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS (London, England), 2012, Jul-17, Volume: 26, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Biomarkers; C-Reactive Protein; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV-1; Humans; Inflammation; Interleukin-6; Lamivudine; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Tumor Necrosis Factor-alpha	2012
GlaxoSmithKline halts AIDS study. The Lancet. Infectious diseases, 2003, Volume: 3, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Dideoxynucleosides; Drug Industry; Drug Therapy, Combination; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir; Treatment Failure	2003
Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients. The Journal of infectious diseases, 2004, Mar-01, Volume: 189, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Multivariate Analysis; Mutation; Organophosphonates; Organophosphorus Compounds; Phenotype; Placebos; Predictive Value of Tests; Regression Analysis; RNA, Viral; Tenofovir; Thymidine	2004
Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate. Journal of acquired immune deficiency syndromes (1999), 2004, Nov-01, Volume: 37, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adenine; Amino Acid Substitution; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Organophosphonates; Phenotype; Placebos; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Tenofovir	2004
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir. AIDS (London, England), 2005, Apr-29, Volume: 19, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV-1; Humans; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Failure; Viral Load; Zidovudine	2005

Other Studies

61 other study(ies) available for tenofovir and Acquired Immune Deficiency Syndrome

Article	Year
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral	2009
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Alanine; Anti-HIV Agents; Anti-Retroviral Agents; Emtricitabine; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; Humans; Tenofovir; United States	2022
Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: A Chinese Cross-Sectional Study. Journal of acquired immune deficiency syndromes (1999), 2022, 07-01, Volume: 90, Issue:3 Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Bone Density; Bone Diseases, Metabolic; Cholesterol; Cross-Sectional Studies; HIV Infections; Humans; Lipoproteins, HDL; Middle Aged; Osteoporosis; Prevalence; Risk Factors; Tenofovir	2022
Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors. Current HIV research, 2022, Volume: 20, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Emtricitabine; HIV Infections; Humans; Interleukin-6; Lamivudine; Middle Aged; Nevirapine; Tenofovir; Weight Loss; Zidovudine	2022
Proximal tubular dysfunction related to tenofovir in people living with HIV/AIDS: a pharmacogenetic study. Pharmacogenetics and genomics, 2022, 12-01, Volume: 32, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Case-Control Studies; Female; HIV Infections; Humans; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Pharmacogenomic Testing; Phosphorus; Tenofovir	2022
Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient. AIDS (London, England), 2022, 12-01, Volume: 36, Issue:15 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Emtricitabine; Fumarates; HIV Infections; Humans; Hypertriglyceridemia; Lamivudine; Tenofovir	2022
Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome. Chinese medical journal, 2022, 11-20, Volume: 135, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cobicistat; Drug Combinations; Emtricitabine; HIV; HIV Infections; Humans; Tenofovir	2022
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept. Journal of nanobiotechnology, 2023, Jan-19, Volume: 21, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Gold; HIV Infections; Humans; Metal Nanoparticles; Peptide Hydrolases; Tenofovir; Tissue Distribution	2023
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort. The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; Humans; Obesity; Tenofovir; Weight Gain	2023
Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study. PloS one, 2023, Volume: 18, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Emtricitabine; HIV Infections; Humans; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir	2023
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV-infected people from the French Dat'AIDS cohort: A propensity score-matched analysis. HIV medicine, 2023, Volume: 24, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Emtricitabine; HIV Infections; Humans; Propensity Score; Retrospective Studies; Tenofovir; Weight Gain	2023
Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PloS one, 2023, Volume: 18, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Canada; Coinfection; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Tenofovir	2023
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV medicine, 2023, Volume: 24, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Retroviral Agents; Child; COVID-19; Hepatitis C; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Tenofovir	2023
Traditional Chinese Medicine Can Improve the Immune Reconstruction of HIV/AIDS Patients. AIDS research and human retroviruses, 2020, Volume: 36, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drugs, Chinese Herbal; HIV Infections; Humans; Immune Reconstitution; Lamivudine; Medicine, Chinese Traditional; Middle Aged; Pilot Projects; Prospective Studies; T-Lymphocytes; Tenofovir; Treatment Outcome; Young Adult	2020
PrEParing for Preexposure Prophylaxis. Journal of doctoral nursing practice, 2020, 03-01, Volume: 13, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Tenofovir; United States	2020
COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling. AIDS care, 2022, Volume: 34, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Aged; Brazil; Cohort Studies; COVID-19; HIV Infections; Humans; Retrospective Studies; SARS-CoV-2; Tenofovir	2022
Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Female; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Male; Middle Aged; Raltegravir Potassium; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; United States; Viral Load; Young Adult	2017
Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study. BMC infectious diseases, 2017, 10-02, Volume: 17, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Ghana; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Stavudine; Tenofovir; Young Adult; Zidovudine	2017
Concomitant AIDS cholangiopathy and Fanconi syndrome as complications of HIV in a single patient. BMJ case reports, 2017, Nov-21, Volume: 2017 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cholangitis; Fanconi Syndrome; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Tenofovir; Zidovudine	2017
Inflammation weakens HIV prevention. Nature medicine, 2018, 04-10, Volume: 24, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Female; Genitalia; HIV; HIV Infections; Humans; Inflammation; Tenofovir	2018
Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria. Bioethics, 2019, Volume: 33, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biomedical Research; Community Participation; Dissent and Disputes; Ethical Analysis; Ethics, Research; HIV; HIV Infections; Humans; Nigeria; Patient Advocacy; Pre-Exposure Prophylaxis; Randomized Controlled Trials as Topic; Research Design; Research Personnel; Tenofovir; Thinking	2019
Progressive disseminated histoplasmosis with concomitant disseminated nontuberculous mycobacterial infection in a patient with AIDS from a nonendemic region (California). BMC pulmonary medicine, 2019, Feb-21, Volume: 19, Issue:1 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Azithromycin; Bacteremia; California; Emtricitabine; Ethambutol; Fungemia; Heterocyclic Compounds, 3-Ring; Histoplasmosis; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Oxazines; Piperazines; Pyridones; Rifabutin; Tenofovir; Tomography, X-Ray Computed	2019
Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study. Journal of acquired immune deficiency syndromes (1999), 2019, 09-01, Volume: 82, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Condoms; Directly Observed Therapy; Disclosure; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Risk-Taking; Sexual and Gender Minorities; Social Networking; South Africa; Surveys and Questionnaires; Tenofovir; Thailand; United States; Young Adult	2019
Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA, 2019, 06-11, Volume: 321, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Advisory Committees; Anti-Retroviral Agents; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; Risk Assessment; Risk Factors; Tenofovir; United States	2019
Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis. AIDS (London, England), 2013, Apr-24, Volume: 27, Issue:7 Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adenine; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cholangitis; Deoxycytidine; Emtricitabine; Humans; Jaundice; Male; Organophosphonates; Plasmapheresis; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome; Viral Load; Young Adult	2013
FDA must publish data on safety and efficacy of prophylactic AIDS drug, court rules. BMJ (Clinical research ed.), 2013, Aug-19, Volume: 347 Topics: Access to Information; Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Organophosphonates; Organophosphorus Compounds; Publishing; Tenofovir; United States; United States Food and Drug Administration	2013
Cobicistat + elvitegravir + emtricitabine + tenofovir. Two new drugs, but no progress. Prescrire international, 2013, Volume: 22, Issue:142 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV-1; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles	2013
Direct and real-time quantification of tenofovir release from ph-sensitive microparticles into simulated biological fluids using (1)h nuclear magnetic resonance. Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Delayed-Action Preparations; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Organophosphonates; Semen; Tenofovir; Vagina	2014
INFECTIOUS DISEASE. Vaginal microbiome affects HIV risk. Science (New York, N.Y.), 2016, Jul-22, Volume: 353, Issue:6297 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Female; Humans; Inflammation; Lactobacillus; Microbiota; Pre-Exposure Prophylaxis; Prevotella; Risk; South Africa; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies	2016
CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load. The AIDS reader, 2008, Volume: 18, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir	2008
Population pharmacokinetics of tenofovir in AIDS patients. Journal of clinical pharmacology, 2008, Volume: 48, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir	2008
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. Medizinische Klinik (Munich, Germany : 1983), 2009, Oct-15, Volume: 104, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir	2009
Trial results finally show potential for microbicidal HIV gel. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Female; Gels; HIV; HIV Infections; Humans; Organophosphonates; South Africa; Tenofovir; Vagina	2010
Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. Joint bone spine, 2011, Volume: 78, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Substitution; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Neurofibromatosis 1; Organophosphonates; Osteomalacia; Phosphates; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome	2011
AIDS: Drugs that prevent HIV infection. Nature, 2011, Jan-20, Volume: 469, Issue:7330 Topics: Acquired Immunodeficiency Syndrome; Adenine; Administration, Intravaginal; Administration, Oral; Animals; Anti-HIV Agents; Condoms; Controlled Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphonates; Placebos; Reverse Transcriptase Inhibitors; Safe Sex; Tenofovir; Vaginal Creams, Foams, and Jellies	2011
Battles with donors cloud Malawi's HIV prevention plan. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2011
Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice. AIDS research and human retroviruses, 2012, Volume: 28, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; HIV Protease Inhibitors; Humans; Male; Middle Aged; Nevirapine; Organophosphonates; RNA, Viral; Spain; Tenofovir; Viral Load	2012
Evaluation of functional respiratory parameters in AIDS patients assisted in the infectious diseases ambulatory care clinic of a tertiary care university hospital in Brazil. Respiratory care, 2012, Volume: 57, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Brazil; Cross-Sectional Studies; Female; Hospitals, University; Humans; Male; Middle Aged; Muscle Strength; Organophosphonates; Outpatient Clinics, Hospital; Prospective Studies; Respiration; Respiratory Function Tests; Respiratory Muscles; Spirometry; Tenofovir	2012
More trials are cut short, but not the debate over their trajectory. Nature medicine, 2012, Jan-06, Volume: 18, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Clinical Trials as Topic; Deoxycytidine; Emtricitabine; Heart Failure; Humans; Niacin; Organophosphonates; Tenofovir	2012
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. Journal of pharmaceutical sciences, 2012, Volume: 101, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Anti-Infective Agents; Cell Line; Chemistry, Pharmaceutical; Excipients; Gels; HIV-1; Humans; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Solubility; Tenofovir; Viscosity	2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS (London, England), 2012, Jul-17, Volume: 26, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Africa; Anti-HIV Agents; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Health Resources; Humans; India; Lopinavir; Male; Medication Adherence; Middle Aged; Mutation; Organophosphonates; Patient Selection; Pilot Projects; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Surveys and Questionnaires; Tenofovir; Thailand; Treatment Failure; Viral Load	2012
Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. The Analyst, 2012, Sep-21, Volume: 137, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, Liquid; Cyclopropanes; Drug Monitoring; Humans; Lamivudine; Organophosphonates; Stavudine; Tenofovir; Zidovudine	2012
New antiretroviral agents. The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2001, Volume: 13, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Deoxycytidine; Dioxolanes; Drugs, Investigational; Emtricitabine; Furans; Guanosine; HIV Fusion Inhibitors; Humans; Imidazoles; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Prodrugs; Protease Inhibitors; Pyridines; Pyrones; Quinazolines; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Tenofovir	2001
Anti-HIV agents. Tenofovir and Videx (ddi) EC--some caution required. TreatmentUpdate, 2002, Volume: 14, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Didanosine; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir	2002
Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Aug-01, Volume: 37, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; HIV; Humans; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load	2003
Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-15, Volume: 37, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Humans; Lopinavir; Male; Organophosphonates; Organophosphorus Compounds; Pyrimidinones; Ritonavir; Tenofovir	2003
[Resistance in a new light. About mutations and their interactions]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Resistance, Multiple, Viral; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis; Organophosphonates; Organophosphorus Compounds; Tenofovir; Treatment Outcome; Virus Replication	2003
[First nucleotide analog with noteworthy safety profile. Tenofovir effective in all stages of the infection]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Humans; Multicenter Studies as Topic; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Virus Replication	2003
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. The American journal of medicine, 2004, Aug-15, Volume: 117, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir	2004
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine	2005
[Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006, Volume: 26, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Aged; Anti-HIV Agents; Fanconi Syndrome; Female; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2006
Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR. American journal of neuroradiology, 2007, Volume: 28, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Diffusion; Diffusion Magnetic Resonance Imaging; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Organophosphonates; Pyrimidinones; Ritonavir; Tenofovir; Zidovudine	2007
[Use study of tenofovir DF in highly active anti-retroviral therapy]. Anales de medicina interna (Madrid, Spain : 1984), 2006, Volume: 23, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Humans; Male; Middle Aged; Organophosphonates; Tenofovir	2006
Tenofovir and abacavir combination therapy: lessons learned from an urban clinic population. AIDS patient care and STDs, 2007, Volume: 21, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Anti-HIV Agents; Baltimore; Dideoxynucleosides; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Failure; Urban Population; Viral Load	2007
Early onset of tenofovir-induced renal failure: case report and review of the literature. TheScientificWorldJournal, 2007, Jul-27, Volume: 7 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiretroviral Therapy, Highly Active; Biopsy; HIV Infections; Humans; Liver; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Time Factors; Treatment Outcome	2007
Test of new vaginal microbicide gel show promise for women. The AIDS reader, 2008, Volume: 18, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Administration, Intravaginal; Anti-Infective Agents, Local; Anti-Retroviral Agents; Female; HIV; HIV Seronegativity; Humans; India; Organophosphonates; Safety; Tenofovir; Treatment Outcome; United States; Vaginal Creams, Foams, and Jellies	2008
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). Journal of virology, 2000, Volume: 74, Issue:20 Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Anti-HIV Agents; Female; HIV-2; Humans; Macaca nemestrina; Organophosphonates; Organophosphorus Compounds; RNA, Viral; Tenofovir; Vagina	2000
[No comparison with NRTI. Tenofovir is robust against resistance trouble]. MMW Fortschritte der Medizin, 2002, Apr-09, Volume: 144 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir	2002
[Nucleotide analog shows effectiveness in previously treated patients. The new kind of HAART]. MMW Fortschritte der Medizin, 2002, Apr-09, Volume: 144 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load	2002
[First nucleotide analog on the market. New drug for the pretreated patient]. MMW Fortschritte der Medizin, 2002, Apr-09, Volume: 144 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Approval; Drug Therapy, Combination; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir	2002
Vaccines. Monkey puzzles. Science (New York, N.Y.), 2002, Jun-28, Volume: 296, Issue:5577 Topics: Acquired Immunodeficiency Syndrome; Adenine; AIDS Vaccines; Animals; Anti-HIV Agents; Clinical Trials as Topic; Haplorhini; HIV; Humans; Killer Cells, Natural; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; SAIDS Vaccines; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viremia	2002